Susquehanna Fundamental Investments LLC Makes New $2.51 Million Investment in Alignment Healthcare, Inc. $ALHC

Susquehanna Fundamental Investments LLC bought a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 105,279 shares of the company’s stock, valued at approximately $2,507,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ALHC. Royal Bank of Canada raised its holdings in Alignment Healthcare by 92.6% during the first quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock worth $1,720,000 after purchasing an additional 44,413 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Alignment Healthcare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock valued at $1,109,000 after purchasing an additional 2,594 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Alignment Healthcare by 79.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock worth $18,112,000 after purchasing an additional 429,703 shares during the period. Woodline Partners LP acquired a new position in Alignment Healthcare during the 1st quarter worth approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Alignment Healthcare by 16.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock worth $5,729,000 after buying an additional 44,452 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Price Performance

ALHC stock opened at $13.40 on Tuesday. The firm has a 50 day moving average of $17.93 and a 200-day moving average of $18.47. The company has a market cap of $2.78 billion, a price-to-earnings ratio of 70.53 and a beta of 1.10. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. Alignment Healthcare, Inc. has a 12-month low of $12.70 and a 12-month high of $25.12.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The business had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same quarter in the prior year, the firm posted $0.07 EPS. The company’s revenue was up 31.6% compared to the same quarter last year. As a group, equities analysts expect that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Insider Transactions at Alignment Healthcare

In other news, EVP Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total transaction of $600,000.00. Following the completion of the transaction, the executive vice president owned 1,103,816 shares of the company’s stock, valued at $26,491,584. The trade was a 2.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00. Following the completion of the sale, the president owned 947,313 shares in the company, valued at $18,519,969.15. This represents a 3.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,009,951 shares of company stock valued at $18,597,287 in the last three months. 5.20% of the stock is owned by company insiders.

Analyst Ratings Changes

ALHC has been the subject of several recent analyst reports. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Barclays cut their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Raymond James Financial downgraded Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and reduced their target price for the company from $22.00 to $19.00 in a report on Monday, August 3rd. TD Cowen restated a “buy” rating on shares of Alignment Healthcare in a research report on Monday, August 3rd. Finally, Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Seven investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $23.60.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.